News & Views20 Dec 2024Nature Biomedical Engineering P: 1-2 Latest Research and Reviews NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression Metaplastic breast cancer is a highly chemoresistant breast cancer subtype with limited therapeutic option...
Analysis: Latest news in breast cancer treatment and preventionJOE PALCA
LATEST NEWS AND RESEARCH ON BREAST CANCER Increase your personal odds of survival by empowering yourself with the latest news and research on breast cancer; news you can use today and incorporate into your integrative cancer treatment programme. "This is just so great to have all this information...
Understanding Systemic Therapies for Breast Cancer: An Overview of Four Key Treatments Breast cancer treatment has evolved significantly, with multiple approaches that go beyond surgery and radiation. Among these, systemic therapies play a crucial role, as they target cancer cells throughout the body,...
October is Breast Cancer Awareness Month according to the Susan G. Komen Foundation, there are more than 4 million breast cancer survivors living in the United States. Oct 9, 2023 03:10 'Just be there' -- Being a caregiver in the fight against breast cancer ...
Read the latest on cancer research and immunotherapy drugs, and get to know the researchers and companies driving advancements in cancer treatment.
"The Office" actress Jenna Fischer on Tuesday revealed that she was diagnosed with breast cancer last year but is now cancer-free after receiving treatment. Oct 8 3 reasons behind the rise in breast cancer, including some you can control There's a troubling rise in breast cancer in wome...
Glioblastoma typically kills within 18 months, but a new type of treatment has kept Nadya El-Afandi's scans clear 17 months after diagnosis. Nov 23 Komen funding innovative breast cancer research in North Texas Komen played a role in the development of all 19 breast cancer drugs approved by ...
Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors A. Giannoudis E. S. Sokol C. Palmieri ResearchOpen Access20 Dec 2024 npj Precision Oncology Volume: 8, P: 282 All Research & Reviews News and Comment Latent spaces for...
Triple-Negative Breast Cancer Now Has a Targeted Agent On March 8, 2019, the US Food and Drug Administration (FDA) approved the PD-L1 inhibitor atezolizumab for first-line treatment of metastatic triple-negative breast... Blog-Breast Cancer-News-Science & Research ...